BioMedInvest AG I is a healthcare-dedicated venture capital fund based in Switzerland, providing private equity and mezzanine financing to early- to mid-stage companies in the biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries in Switzerland and neighbouring regions (Alpine Rim). BioMedInvest I was closed in 2003.
BioMedInvest's investment strategy allows for investments in start-up companies looking for first round funding through to later-stage or spin-off companies focused on product development in the biotechnology, emerging pharmaceuticals, healthcare and medical technology sectors.
The amount we aim to invest over the life time of our portfolio companies is about CHF 1-10 million. BioMedInvest typically plays the lead or co-lead investor role structuring the transaction and syndicating with other venture capital firms.